To assess the efficacy of intranasal corticosteroids on asthma outcomes in people with rhinitis and asthma.
评估合并气喘及鼻炎患者使用鼻内类固醇对气喘的效果。
Results:The local efficacy and safety of Budesonide and Fluticasone are better than other intranasal corticosteroids.
结果：布地松纳和氟地卡松作用于鼻腔的局部效能和全身安全性较之其它类固醇更好；
Intranasal corticosteroids (INSs) effectively reduce the nasal inflammation that is a root cause of allergic rhinitis.
鼻腔炎症是变态反应性鼻炎的根本原因，而鼻内皮质激素能有效减轻鼻腔炎症。
They may represent two manifestations of the same united airway disease and therefore intranasal corticosteroids (INCS) could improve asthma.
这两种疾病也许代表著同一种气道疾病的两种表现，因此，鼻内类固醇（INCS）可改善气喘。
Randomised controlled trials comparing intranasal corticosteroids to intranasal placebo or to other traditional asthma treatments were included.
纳入比较鼻内皮质类固醇及鼻内安慰剂或其他传统气喘治疗的随机对照试验。
The combination of intranasal plus intrabronchial corticosteroids should remain the current clinical practice until more research is done.
再有更多研究完成之前，合并鼻内及支气管内皮质类固醇仍应是目前临床处置的方式。
The combination of intranasal plus intrabronchial corticosteroids should remain the current clinical practice until more research is done.
再有更多研究完成之前，合并鼻内及支气管内皮质类固醇仍应是目前临床处置的方式。
应用推荐